AG003OQH

104376-79-6 | Ceftriaxone disodium salt

Chemical structure of Ceftriaxone disodium salt, CAS 104376-79-6
AG003OQH
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 104376-79-6
Catalog Number AG003OQH(AGN-PC-0OTAE7)
Chemical Name Ceftriaxone disodium salt
EC Number 277-405-6
IUPAC Name sodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChI InChI=1S/C18H18N8O7S3.Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);/q;+1/p-1/b24-8-;/t9-,15-;/m1./s1
InChI Key YOBPSXOHCHDCMU-VKZZUTNHSA-M
MDL Number MFCD01750405
Molecular Formula C36H46N16Na4O21S6
Molecular Weight 1323.1941
SMILES O=C(C(N12)=C(CSC(N(C)N=C3[O-])=NC3=O)CSC2C(NC(/C(C4=CSC(N)=N4)=N/OC)=O)C1=O)[O-].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].O=C(C(N56)=C(CSC(N(C)N=C7[O-])=NC7=O)CSC6C(NC(/C(C8=CSC(N)=N8)=N/OC)=O)C5=O)[O-].[Na+].[Na+].[Na+].[Na+]
Synonyms
Anhydrous Ceftriaxone Sodium, Benaxona, Cefatriaxone, Cefaxona, Ceftrex, Ceftriaxon, Ceftriaxon Curamed, Ceftriaxon Hexal, Ceftriaxona Andreu, Ceftriaxona LDP Torlan, Ceftriaxone, Ceftriaxone Irex, Ceftriaxone Sodium, Ceftriaxone Sodium, Anhydrous, Ceftriaxone, Disodium Salt, Ceftriaxone, Disodium Salt, Hemiheptahydrate, Lendacin, Longacef, Longaceph, Ro 13 9904, Ro 13-9904, Ro 139904, Ro-13-9904, Ro13 9904, Ro13-9904, Ro139904, Rocefalin, Rocefin, Rocephin, Rocephine, Tacex, Terbac, CEFTRIAXONE SODIUM, Rocephin, ceftriaxone, Tartriakson, Ceftriaxone disodium, 104376-79-6, Ceftriaxone Sodium [USP], EINECS 277-930-0, Ro 13-9904/001, X 13-9904, OCTX, CEFTRIAXONE SODIUM TRIHYDRATE, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, (6R-(6alpha,7beta(Z)))-, SCHEMBL537013, CHEMBL1200995, AKOS015961150, AC-1851, BC205730, LS-150032, I06-1763, I06-2130, sodium (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, Lendacin, Longaceph, Biotrakson, Ceftriaxona, Ceftriaxonum, Ceftriaxone [INN:BAN], Ceftriaxone [USAN:JAN], Ceftriaxonum [INN-Latin], Ceftriaxona [INN-Spanish], UNII-023Z5BR09K, UNII-R598PB148Q, Ceftriaxone [USAN:INN:JAN], Ceftriaxone in plastic container, C18H18N8O7S3.2Na, C18H18N8O7S3, UNII-75J73V1629, DRG-0071, EINECS 277-405-6, Ceftriaxone sodium [USAN:USP:JAN], Ceftriaxone sodium, 97% - 1G 1g, Ro 13-9904, C18-H18-N8-O7-S3, CID9570832, Ro 139904, Ro-139904, C18-H18-N8-O7-S3.2Na, C18H18N8O7S3.7/2H2O.2Na, Ceftriaxone disodium salt hemiheptahydrate, Ceftriaxone and Dextrose in Duplex Container, ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER, C18-H18-N8-O7-S3.7/2H2-O.2Na, 73384-59-5, 74578-69-1, (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, disodium salt, [6R-[6alpha,7beta(Z)]]-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, sodium salt, hydrate (2:4:7), (6R,7R)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited